Cas:1131594-22-3 3-bromo-4-(2-methylpropanoylamino)benzoic acid manufacturer & supplier

We serve Chemical Name:3-bromo-4-(2-methylpropanoylamino)benzoic acid CAS:1131594-22-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-bromo-4-(2-methylpropanoylamino)benzoic acid

Chemical Name:3-bromo-4-(2-methylpropanoylamino)benzoic acid
CAS.NO:1131594-22-3
Synonyms:3-bromo-4-isobutyramidobenzoic acid
Molecular Formula:C11H12BrNO3
Molecular Weight:286.12200
HS Code:2924299090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:69.89000
Exact Mass:285.00000
LogP:3.39130

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3-bromo-4-isobutyramidobenzoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-bromo-4-isobutyramidobenzoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-bromo-4-isobutyramidobenzoic acid Use and application,3-bromo-4-isobutyramidobenzoic acid technical grade,usp/ep/jp grade.


Related News: “Alcami supported this product with supply constraints and successfully developed a capsule formulation for two dosage strengths,” she explains. “The formulations group performed studies at a micro-laboratory scale using a scientifically-based approach to identify a lead prototype. 1-nitro-4-[2-(4-nitrophenyl)ethyl]benzene manufacturers Biogen’s top research chief, Dr. Al Sandrock, defended the drug in an open letter released alongside the company’s earnings Thursday, saying its approval has been subject to “extensive misinformation and misunderstanding.” 1-methyl-3-(oxolan-3-ylmethyl)urea suppliers Charles River Laboratories and AstraZeneca have maintained a strategic partnership since 2012, providing AstraZeneca with outsourced regulated safety and development support on a range of treatments and vaccines, including testing and facilitating the deployment of the vaccines Vaxzevria for COVID-19 and Fluenz for seasonal infleunza. 3,5-Dimethoxy-2-pyrazinamine vendor & factory.